Live Quote · NASDAQLYELHealthcare· Biotechnology

Lyell Immunopharma, Inc.

$13.80▲ 1.62%(+$0.22)
MKT CAP $339.28MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
65
Valuation
20
Profitability
10
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LYEL research report →

Analyst Price Target
$39.50+186.2% vs. today

Range $34 – $45

Analyst RatingBuy
3 Buy3 Hold1 Sell

Price Chart

-20.83% · this period
$38.60$23.05$7.51Nov 20May 26Nov 20
52-Week Range17% of range
Low
$7.20
Current
$13.80
High
$45.00